Cross-Protective Antibodies against Common Endemic Respiratory Viruses

The authors presented the discovery, in vitro characterization, and in vivo efficacy testing of two cross-neutralizing monoclonal antibodies, one targeting both human parainfluenza virus types one and three, and the other targeting both respiratory syncytial virus and human metapneumovirus.